The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life and psychological distress in patients with acute myeloid leukemia (AML).
 
Julia Carp
No Relationships to Disclose
 
Lauren Waldman
No Relationships to Disclose
 
Showly Nicholson
No Relationships to Disclose
 
Lara Traeger
No Relationships to Disclose
 
Gregory A. Abel
No Relationships to Disclose
 
Joseph Greer
Research Funding - Pfizer (Inst)
 
Amir Tahmasb Fathi
Honoraria - Agios; Baxalta; Merck; Seagen; Tolero Pharmaceuticals
Research Funding - Celgene (Inst); Exelixis (Inst); Seagen (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Agios
 
David P. Steensma
Stock and Other Ownership Interests - ARIAD
Consulting or Advisory Role - Akebia Therapeutics; Amgen; Celgene; H3 Biomedicine; Janssen Oncology; Novartis; Pfizer; Takeda
 
Thomas William LeBlanc
Honoraria - Celgene; Helsinn Therapeutics; Quintiles
Consulting or Advisory Role - Epi-Q; Flatiron Health; Helsinn Therapeutics; Heron; Otsuka; Pfizer
Research Funding - AstraZeneca (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Celgene; Heron; Otsuka; Pfizer
 
Daniel J. DeAngelo
Consulting or Advisory Role - Amgen; ARIAD; Bristol-Myers Squibb; Celgene; Immunogen; Incyte; Novartis; Pfizer; Shire
 
Martha Wadleigh
No Relationships to Disclose
 
Gabriela Hobbs
No Relationships to Disclose
 
Andrew Mark Brunner
Consulting or Advisory Role - Celgene
Research Funding - Celgene (Inst); Novartis (Inst); Takeda (Inst)
 
Philip C. Amrein
No Relationships to Disclose
 
Richard M. Stone
Consulting or Advisory Role - Abbvie; Agios; Amgen; Bristol-Myers Squibb; Celator; Celgene; Fujifilm; Juno Therapeutics; Karyopharm Therapeutics; Merck; Novartis; Ono Pharmaceutical; Roche/Genentech; Theradex
Research Funding - Agios (Inst); Celator (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst)
 
Jennifer S. Temel
Research Funding - Pfizer (Inst)
 
Areej El-Jawahri
No Relationships to Disclose